Skip to content
OpenCapital
Get started

Achieve Life Sciences ACHV Interest Income

Interest Income at other companies

Sionna Therapeutics, Inc. Common Stock logo
Sionna Therapeutics, Inc. Common StockSION
$2.82M-6.0%

Other financials

Income statement

See full
Net income-$10.2M+20.7%
EPS (diluted)-$0.19+48.6%

Balance sheet

See full
Cash & equivalents$28.1M+116%
Total debt$5.6M+332%
Total equity$10.7M+3.9%
Total assets$33.1M+21.0%

Cash flow

See full
Operating cash flow-$6.9M+37.5%
CapEx$750.0—
Free cash flow-$12.4M—

Valuation

See full
Market cap$585.16M+404%
Enterprise value$562.71M+439%

Returns & leverage

See full
Return on equity-496.1%-906pp
Debt / equity0.5×+0.4×
Current ratio2.6×-0.9×

Where this comes from

Reported directly by Achieve Life Sciences in its filing.

Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.

The official record: Achieve Life Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Achieve Life Sciences's interest income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Achieve Life Sciences's interest income?
Achieve Life Sciences (ACHV) reported interest income of $297K in Q1 2026.
How has Achieve Life Sciences's interest income changed year-over-year?
Achieve Life Sciences's interest income decreased by 7.8% year-over-year, from $322K to $297K.
What is the long-term trend for Achieve Life Sciences's interest income?
Over 4 years (2021 to 2025), Achieve Life Sciences's interest income has grown at a 206.2% compound annual growth rate (CAGR), from $17K to $1.5M.
What does interest income mean?
Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.